Seaport Therapeutics director granted 12,258 options
Seaport Therapeutics, Inc. director David E. Wheadon received a grant of stock options covering 12,258 shares of common stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Seaport Therapeutics, Inc. director David E. Wheadon received a grant of stock options covering 12,258 shares of common stock. The options have an exercise price of $18.00 per share and expire on April 29, 2036. All 12,258 underlying shares vest in full on April 30, 2027, subject to his continued service, and this grant represents his entire reported option position in this filing.
Insider Trade Summary
Grant/Award: 12,258 shares
Grant/Award
1 txn
Insider
Wheadon David E.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 12,258 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 12,258 contracts (Direct)
Holdings Before and After:
Stock Option (Right to Buy), 0 to 12,258 contracts (Direct)
Footnotes (1)
- F1. The shares underlying this option shall vest in full on April 30, 2027, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Option grant size: 12,258 options
Exercise price: $18.00 per share
Underlying shares: 12,258 shares
+3 more
6 metrics
Option grant size
12,258 options
Grant to director David E. Wheadon
Exercise price
$18.00 per share
Stock option strike price
Underlying shares
12,258 shares
Common stock underlying the options
Expiration date
April 29, 2036
Option term end
Vesting date
April 30, 2027
Full vesting if service continues
Holdings after grant
12,258 options
Total derivative holdings following transaction
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 18.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-04-29T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"shall vest in full on April 30, 2027, subject to the Reporting Person's continued service"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Seaport Therapeutics (SPTX) director David E. Wheadon report on this Form 4?
David E. Wheadon reported receiving a stock option grant for 12,258 shares of Seaport Therapeutics common stock, exercisable at $18.00 per share. The filing reflects a compensation-related award rather than an open-market purchase or sale of shares.
What is the exercise price and expiration date of the Seaport Therapeutics (SPTX) options?
The options have an exercise price of $18.00 per share and expire on April 29, 2036. This means the director can choose to buy shares at $18.00 any time before that expiration date, once the options are vested.
When do David E. Wheadon’s Seaport Therapeutics (SPTX) options vest?
All 12,258 shares underlying the option grant vest in full on April 30, 2027. Vesting is conditioned on the director’s continued service with Seaport Therapeutics through that vesting date, according to the disclosed footnote.
AI-generated analysis. How Rhea-AI works. Not financial advice.
